ロード中...
Multifunctional nanoagent for thrombus-targeted fibrinolytic therapy
AIMS: Current thrombolytic therapies rely upon exogenous plasminogen activators (PA) to effectively lyse clots, thereby restoring blood flow and preventing tissue and organ death. Yet, these PAs may also impair normal hemostasis which may lead to life-threatening bleeding, including intracerebral he...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3360120/ https://ncbi.nlm.nih.gov/pubmed/22348271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/nnm.11.179 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|